Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | Allogeneic therapy highlights at Advanced Therapies Week 2022

Jeff Liter • 27 Jan 2022
Advanced Therapies Week 2022
General

Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, provides his highlights from Advanced Therapies Week 2022, including advances in allogeneic therapy manufacturing. He discusses developments that have led to more consistent donor material and media expansion techniques, as well as the cooperation between various companies to propel progress in the field. This interview took place at Advanced Therapies Week 2022.

More from Jeff Liter

2:04
Advances in allogeneic γδ T cells
Jeff Liter • 27 Jan 2022
1:58
LMY-920 in non-Hodgkin lymphoma
Jeff Liter • 27 Jan 2022
1:51
The benefits of universal immune receptors in cell therapy
Jeff Liter • 27 Jan 2022

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch • 6 Apr 2022
The content of VJRegenMed is intended for healthcare professionals